A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease.
Wun T, Soulieres D, Frelinger AL, Krishnamurti L, Novelli EM, Kutlar A, Ataga KI, Knupp CL, McMahon LE, Strouse JJ, Zhou C, Heath LE, Nwachuku CE, Jakubowski JA, Riesmeyer JS, Winters KJ.
Wun T, et al. Among authors: kutlar a.
J Hematol Oncol. 2013 Feb 17;6:17. doi: 10.1186/1756-8722-6-17.
J Hematol Oncol. 2013.
PMID: 23414938
Free PMC article.
Clinical Trial.